Efficacy Study of Raloxifene to Induce Ovulation in Polycystic Ovarian Syndrome

Stopped early · Not applicable

Conditions studied: Polycystic Ovarian Syndrome

In brief

This study examines Raloxifene versus Clomiphene to induce ovulation in women with polycystic ovarian syndrome (PCOS).

Key facts

Study ID

NCT01607320

Run by

Bruce Lessey

People needed

3

Starts

2012-06-01

Expected to finish

2013-03-01

Last updated by the study team

2018-09-20

Who can join

Age: 18 and older, up to 36. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Women aged 18 to 36
• BMI > 19 \& < 40
• PCOS diagnosis as evidenced by:
• Oligo- and/or anovulation (< 6 cycles per year) and one of the following:
• Clinical and/or biochemical signs of hyperandrogenism
• Polycystic ovaries and exclusion of other aetiologies (congenital adrenal hyperplasias, androgen-secreting tumors, Cushing's syndrome)

You may not qualify if…

• Use of ovulation induction agents within the past 6 months
• Positive pregnancy test before taking study medications
• History or current thromboembolic disorder
• Coronary artery disease such as heart attack or stroke
• Tobacco use or history within the past 6 months
• History of pelvic inflammatory disease and tubal factor infertility
• Congenital adrenal hyperplasia
• Diabetes Mellitus
• Any subject on Metformin must "wash out" for 30 days prior to screening
• History of endometriosis
• Known male factor infertility

Where it is running

• Greenville Hospital System — Greenville, South Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.